Nakashima E, Ishikawa F, Sato H, Deguchi Y, Tamai I, Matsushita R, Ichimura F, Tsuji A
Hospital Pharmacy, Kanazawa University, Japan.
J Pharm Sci. 1988 Jun;77(6):481-8. doi: 10.1002/jps.2600770604.
In order to quantitatively describe the peritoneal transport of drugs, this paper proposes a kinetic model that is based on the hydrodynamic pore theory of transcapillary exchange, and incorporates an explicit description of volume and osmolality changes in the dialysate. Sulfisoxazole (SIX) and benzoic acid (BA) were used as model compounds. Following intraperitoneal administration of dialysate in rats, the osmolality, volume, and drug concentration in the dialysate were measured with respect to time. The obtained data were analyzed to give hydrodynamic parameters for solvent and a solute (including drug) by a computer-aided curve-fitting procedure according to the differential equations derived from the model. The present method, requiring no approximation of the changes in dialysate volume, made it possible to predict the concentration profiles of BA under different initial conditions of dialysate (i.e., different osmolality and volume). Solvent drag effect contributed little to the peritoneal transport of SIX and slightly to that of BA. It was also found that the peritoneal transport of BA is blood-flow limited while that of SIX is diffusion limited.
为了定量描述药物的腹膜转运,本文提出了一种基于跨毛细血管交换的流体动力学孔理论的动力学模型,并明确描述了透析液中体积和渗透压的变化。选用磺胺异恶唑(SIX)和苯甲酸(BA)作为模型化合物。在大鼠腹腔内注入透析液后,测量透析液的渗透压、体积和药物浓度随时间的变化。根据从模型导出的微分方程,通过计算机辅助曲线拟合程序对所得数据进行分析,以给出溶剂和溶质(包括药物)的流体动力学参数。本方法无需近似透析液体积的变化,使得预测不同透析液初始条件(即不同渗透压和体积)下BA的浓度分布成为可能。溶剂拖曳效应在SIX的腹膜转运中作用较小,在BA的腹膜转运中作用稍大。还发现BA的腹膜转运受血流限制,而SIX的腹膜转运受扩散限制。